Combining financial coaching with smoking cessation support

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study is a two-arm, parallel-group randomized controlled trial aimed at evaluating the effectiveness of integrated financial and smoking cessation counseling for low-income smokers. A total of 900 participants will be recruited and randomly assigned to either receive standard smoking cessation counseling or the integrated approach, which includes financial coaching. Both groups will receive 8 weeks of nicotine replacement therapy, and outcomes will be assessed through surveys and biochemical verification of smoking abstinence at 12 months. The study also aims to compare the costs associated with each treatment arm.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age ≥18 years,
* smokes ≥5 cigarettes per day,
* interested in receiving smoking and financial counseling,
* self-reported income below 200% of the current federal poverty level,
* New York City resident,
* speaks English or Spanish language (the interventions and measures have not been validated in other languages),
* able to provide informed consent, and
* does not have a representative who manages his/her funds.

Exclusion Criteria

* people who know a current past study participant (to avoid intervention contamination)
* People who have a medical contraindication to using nicotine replacement therapy:
* allergy to nicotine patch
* pregnancy or intention to become pregnant over the next 12 months
* breastfeeding
* heart attack in the past 2 months
* underlying arrhythmia
* ongoing or worsening angina.

Where it's running

• NYU Langone Health
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Erin Rogers, DrPH — NYU Langone Health
• Study coordinator: Erin Rogers, DrPH
• Email: erin.rogers@nyulangone.org
• Phone: 646-501-2544

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Salivary IL-8 and Serum IL-6 as Biomarkers to Distinguish Oral Premalignant Disorders in Smokers and Never-Smokers

  This study tests whether salivary IL-8 and blood IL-6 can help tell apart adults with oral premalignant conditions from those with healthy mouths, and whether smoking influences these markers.

  Recruiting British University In Egypt · Cairo · NCT07915570

• Access to multiple tobacco flavors to help adult cigarette smokers quit using e-cigarettes

  This study tests whether giving adult smokers an e-cigarette with a choice of flavors helps them quit smoking by the end of 13 weeks.

  Recruiting at 5 sites RAI Services Company · Fort Lauderdale, Florida and 4 other locations · NCT07879638

• Smoking, MFN1, and NLRP3 Levels in Gum Fluid Across Periodontal Health and Disease

  This study tests whether smoking changes MFN1 and NLRP3 protein levels in the fluid around the gums for adults with or without periodontitis.

  Recruiting Abant Izzet Baysal University · Bolu, Central · NCT07826728

• Heated tobacco access and cigarette quitting among adult smokers

  This study tests whether giving adult smokers access to a heated tobacco product helps them quit smoking by the end of 3 months.

  Recruiting at 9 sites RAI Services Company · Brandon, Florida and 8 other locations · NCT07710820

• How flavors of ENDS might help adults quit smoking their usual cigarettes

  This study tests whether giving adults who smoke their regular cigarettes an electronic nicotine delivery system with different flavors can help them quit smoking their usual cigarettes after 3 months.

  Recruiting at 7 sites RAI Services Company · Maitland, Florida and 6 other locations · NCT07598136

• Comparing chest PNF and chest mobility exercises for university students who smoke

  This trial tries two chest exercise programs to see if they help 18–24-year-old university students who smoke breathe better and improve lung function.

  Recruiting University of Yalova · Yalova, Yalova · NCT07488741

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.